← Back to Clinical Trials
Recruiting Phase 3 NCT04415983
Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children
Trial Parameters
Condition Helicobacter Pylori Infection
Sponsor Tanta University
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 100
Sex ALL
Min Age N/A
Max Age 18 Years
Start Date 2020-06-01
Completion 2030-10-01
Interventions
NitazoxanideClarithromycinMetronidazole
Brief Summary
Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children
Eligibility Criteria
Inclusion Criteria: \- Positive helicobacter infection. Exclusion Criteria: * Previous treatment for H. Pylori.
Related Trials
NCT04415983
Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children
View Trial →
NCT06660342
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
View Trial →
NCT07139366
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treat
View Trial →